Dileepan K, Feldt MM Type 2 diabetes mellitus in children and adolescents. Pediatr Rev. 2013 Dec;34(12):541-8. doi: 10.1542/pir.34-12-541.
Gurnani M, Birken C, Hamilton J Childhood Obesity: Causes, Consequences, and Management. Pediatr Clin North Am. 2015 Aug;62(4):821-40. doi: 10.1016/j.pcl.2015.04.001. Epub 2015 May 23.
Hall R, Gardner K, Rees DC, Chakravorty S High body mass index in children with sickle cell disease: a retrospective single-centre audit. BMJ Paediatr Open. 2018 Oct 23;2(1):e000302. doi: 10.1136/bmjpo-2018-000302. eCollection 2018.
Hannon TS, Arslanian SA The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes. Ann N Y Acad Sci. 2015 Sep;1353:113-37. doi: 10.1111/nyas.12939. Epub 2015 Oct 8.
Hannon TS, Gungor N, Arslanian SA Type 2 diabetes in children and adolescents: a review for the primary care provider. Pediatr Ann. 2006 Dec;35(12):880-7. doi: 10.3928/0090-4481-20061201-02. No abstract available.
Hardy SJ, Bills SE, Wise SM, Hardy KK Cognitive Abilities Moderate the Effect of Disease Severity on Health-Related Quality of Life in Pediatric Sickle Cell Disease. J Pediatr Psychol. 2018 Sep 1;43(8):882-894. doi: 10.1093/jpepsy/jsy019.
Ihmels MA, Welk GJ, Eisenmann JC, Nusser SM, Myers EF Prediction of BMI change in young children with the family nutrition and physical activity (FNPA) screening tool. Ann Behav Med. 2009 Aug;38(1):60-8. doi: 10.1007/s12160-009-9126-3. Epub 2009 Oct 6.
Malik VS, Schulze MB, Hu FB Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr. 2006 Aug;84(2):274-88. doi: 10.1093/ajcn/84.1.274.
Ribeiro RT, Macedo MP, Raposo JF HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions. Curr Diabetes Rev. 2016;12(1):14-9. doi: 10.2174/1573399811666150701143112.
Siddiqui S, Malatesta-Muncher R Hypertension in Children and Adolescents: A Review of Recent Guidelines. Pediatr Ann. 2020 Jun 1;49(6):e250-e257. doi: 10.3928/19382359-20200513-01.
Small L, Bonds-McClain D, Gannon AM Physical activity of young overweight and obese children: parent reports of child activity level compared with objective measures. West J Nurs Res. 2013 May;35(5):638-54. doi: 10.1177/0193945912471976. Epub 2013 Jan 8.
Tanner JM, Davies PS Clinical longitudinal standards for height and height velocity for North American children. J Pediatr. 1985 Sep;107(3):317-29. doi: 10.1016/s0022-3476(85)80501-1.
Vendrame F, Olops L, Saad STO, Costa FF, Fertrin KY Hypocholesterolemia and dysregulated production of angiopoietin-like proteins in sickle cell anemia patients. Cytokine. 2019 Aug;120:88-91. doi: 10.1016/j.cyto.2019.04.014. Epub 2019 May 1.
Zhou J, Han J, Nutescu EA, Galanter WL, Walton SM, Gordeuk VR, Saraf SL, Calip GS Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis. Br J Haematol. 2019 Apr;185(1):116-127. doi: 10.1111/bjh.15773. Epub 2019 Feb 3.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.